06/2023

News Feed Opinion Career Insight Dialogues Blog Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

06/2023

Jun 17, 2023, 15:37 | Drugs
Super results in transfusion-dependent patients on ruxolitinib - Francesco Passamonti
It was a great honor to present at EHA 2023 on behalf of all investigators…
Jun 17, 2023, 15:23 | Blog
It's undeniably a new era in Bone Marrow Transplant - Shernan Holtan
Something I didn't expect to see during my career: Severe acute and chronic Graft-versus host…
Jun 17, 2023, 13:53 | Blog
By meticulously following a checklist, we can systematically address critical points before, during, and after surgeries - Mark Clemens
Today, at MD Anderson Cancer Center, Perioperative Services proudly joins the nationwide celebration of National Time Out Day.…
Jun 17, 2023, 07:54 | Positive
Introducing prominent Editorial Board Members of OncoDaily.com
Introducing prominent Editorial Board Members of OncoDaily.com! We are proud to have such esteemed experts…
Jun 17, 2023, 05:32 | Opinion
Africa has abt 109 open oncology clinical trials and less than 9 in Nigeria - Runcie C.W. Chidebe
Quoting Runcie C.W. Chidebe on LinkedIn, “Africa has abt 109 open oncology clinical trials &…
Jun 16, 2023, 19:55 | Blog
You are not a leader yet, But you can become one - Catalina Müller
You are not a leader...yet. But you can become one. This is what I have…
Jun 16, 2023, 19:38 | Drugs
Dasatinib 50 mg daily is as effective and less toxic than 100 mg daily for newly diagnosed CML-CP
In a post by Hagop Kantarjian on Twitter, it says, "Dasatinib 50 mg daily is…
Jun 16, 2023, 19:17 | Blog
Today, we were listed as the authors of 3 most read research papers in JAMA this week - Reshma Jagsi
In 1995, Allison Walsh Allison Kurian, Rosovsky Rachel and I matriculated to med school together…
Jun 16, 2023, 19:00 | Insight
Radiation is said to be not needed in >90% of patients with a subset of locally advanced rectal cancers - Ray DuBois
Radiation is said to be not needed in >90% of patients with a subset of…
Jun 16, 2023, 18:43 | Blog
This is a first in human clinical trial utilizing CD34+ selected allografts with gene-edited CD33neg hematopoietic stem cells from HLA matched related or unrelated donors for patients with AML - Guenther Koehne
All: 256 Posts: 131 - 140